Moonwalk Team

Chris Dimitropoulos

Chris has 20+ years of experience as a biotech therapeutics and healthcare investor, executive and entrepreneur. Focused on helping companies develop medicines and technologies that improve the lives of patients in need.
Current board seats (alphabetical): Apnimed, Biolinq, Cour Pharmaceuticals, HistoSonics, Moonwalk Biosciences, Transcend Therapeutics, stealth neuromodulation company
Past board seats: HI-Bio (acquired), Alto Neuroscience (IPO-ANRO), Lenz Therapeutics (public-LENZ), Dunad Therapeutics
Other IPO/M&A: Metsera (IPO-MTSR)